Tenax Therapeutics
Robyn Hunter joined the Board in 2022. She has served as the Chief Financial Officer of Fortress Biotech, Inc. since June 2017, and from August 2011 to June 2017, she served as the Vice President and Corporate Controller of Fortress Biotech. Ms. Hunter served as Senior Vice President and Chief Financial Officer of Schochet Associates, Inc. from January 2006 to May 2011. She served as the Corporate Controller for Indevus Pharmaceuticals, Inc. from August 2004 to January 2006. Ms. Hunter held several positions from Accounting Manager to Vice President and Treasurer of The Stackpole Corporation from 1990 to 2004. She holds a B.A. in Economics from Union College in Schenectady, New York.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Tenax Therapeutics
1 followers
Tenax Therapeutics is focused on developing and commercializing pharmaceutical products that improve outcomes for patients who require treatment for various critical care conditions.